Barclays reaffirmed their overweight rating on shares of Microsoft (NASDAQ:MSFT) in a research report sent to investors on Friday morning. Barclays currently has a $117.00 target price on the software giant’s stock, up from their previous target price of $108.00.
On the latest Lucky Seven update, we initiated a buy on Viking Therapeutics (NASDAQ:VKTX) citing: (1) recent institutional buying, (2) price support, and (3) conviction in its pipeline and long-term prospects.
A Technical Look
Fortunately, we were just in time for the longest white candle since early February, appropriate for a delicious birthday cake:
Hill-Rom Holdings Inc (NYSE:HRC) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. HRC’s market value is $5.1 billion which falls in the top quarter of its industry group. Currently, the stock’s Portfolio Grader ranking places it 35 among the 164 companies in this....More>>>
In March of last year, I looked at MuleSoft (MULE) which has just gone public at the time. I concluded that shares of the “donkey” business have seen a great debut, driven by the rapid growth of the business and narrowing of the losses.
Shares traded in the mid-20s at the time and have mostly traded in a $20-25 range ever since, before jumping towards the $30 mark following the....More>>>
It’s been a busy week for the folks at Patriot One Technologies (OTCQB: PTOTF) (TSX VENURE: PAT.V), and the way the stock is moving this morning, it doesn’t look like anyone is going to be leaving early today to get a jump on the weekend, either. On Tuesday of this week Patriot One announced a big bump in sales over the past three months of their award winning PATSCAN....More>>>
Maura Shaughnessy has seen plenty of ups and downs during her quarter-century tenure at the helm of MFS Utilities (MMUFX). Now, after a few years of so-so results, her fund is again among the leaders in its group.
See Also: 12 Dividend Aristocrats for Every Month of the Year
Shaughnessy invests mostly in bargain-priced electricity, natural gas and water utilities, holding a....More>>>
Today, our Under the Radar Moversnewsletter suggested shortingsmall cap California Central Coast based bank holding stockHeritage Oaks Bancorp (NASDAQ: HEOP):
The chart of Heritage Oaks Bancorp speaks for itself. After a 68% runup in just two months, HEOP shares are starting to feel the weight of that big gain. Today it started to pay the price, logging a bar — a loss — that suggests....More>>>
Warren Buffett, chairman and chief executive officer of Berkshire Hathaway Inc., laughs while playing cards on the sidelines of the Berkshire Hathaway annual shareholders meeting in Omaha, Nebraska on Sunday, May 1, 2016. (Photo Credit: Daniel Acker/Bloomberg)
Warren Buffett made $12 billion in 2016 and reclaimed his position as the second richest person in the world.
Varian Medical Systems Inc. (NYSE: VAR) sure sawa pop on Thursday, just a day ahead of earnings from General Electric Co. (NYSE: GE). These two companies might not be tied together on normal days. This time it’s because of merger rumors. Varian shares were up as much as 10% on Thursday after a report that GE might be acquiring the medical devices and equipment company.
Ingevity (NYSE:NGVT) had its price target increased by Loop Capital to $89.00 in a research note published on Wednesday. The brokerage currently has a $90.05 rating on the stock. The analysts noted that the move was a valuation call.
A number of other analysts have also weighed in on the
BP, (BP) gets a lot of interest from investors, and has a lot of articles written about it. Many of these articles feature the generous dividend the company pays, upon which many retirees rely for income. Other articles feature the depressed stock price relative to its cohort group,
The S&P 500 Consumer Staples Index has tanked 6% over the past month amid mixed first-quarter earnings from the group's biggest names. For some on Wall Street, Coca-Cola's (KO) report card disappointed in the area of pricing power both in the U.S. and Eur